spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  PLIVA d.d. 

 HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2008
Barr Announces Approval of Generic Aredia(R) Injection, 30mg/mL, 60mg/mL and 90mg/mL Injectable
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jul 2008
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Jul 2008
Teva to Acquire Barr
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jun 2008
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 28 Mar 2008
Barr Announces Reorganization of Senior Management, Business Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2008
Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 5 Mar 2008
Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Mar 2008
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
Biopharmaceuticals Litigation
 HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Feb 2008
Barr Launches Generic Fosamax(R) Tablets, 70 mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 11 Jan 2008
Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 9 Jan 2008
Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
Biopharmaceuticals Generics
 HSMN NewsFeed - 2 Jan 2008
Barr Confirms Patent Challenge of Argatroban(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 Jan 2008
Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Dec 2007
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Nov 2007
Barr Confirms Patent Challenge of Focalin(R) XR
Biopharmaceuticals Generics
 HSMN NewsFeed - 30 Oct 2007
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Oct 2007
Barr's Generic Version of Estrostep(R) Fe Tablets Approved
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Oct 2007
Barr and Par Settle Diazepam Rectal Gel Patent Challenge with Valeant
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2007
Barr Confirms Patent Challenge of UROXATRAL(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Aug 2007
Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
Biopharmaceuticals Generics
 HSMN NewsFeed - 2 Aug 2007
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Barr Confirms Patent Challenge of TEMODAR(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 16 Jul 2007
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Jul 2007
Barr Confirms Patent Challenge of Aggrenox(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 9 Jul 2007
Barr Announces Approval of Generic Dostinex(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Effexor(R) Tablets, 25mg, 37.5mg, 50mg, 75mg and 100mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Jun 2007
Barr Receives Approval for Generic VESANOID(R) Capsules, 10 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Risperdal(R) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Jun 2007
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 May 2007
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 May 2007
Barr Receives Approval for Generic Nimotop(R) Capsules, 30 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Apr 2007
Barr Confirms Patent Challenge of Ambien CR(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Jan 2007
Barr Launches Generic PROSCAR(R) Tablets, 5 mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Jan 2007
Barr Confirms Generic Thalomid(R) Suit Filed
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jan 2007
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Biopharmaceuticals Generics Endocrinology
 HSMN NewsFeed - 18 Jan 2007
Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Dec 2006
Barr Confirms Generic Thalomid(R) Capsule, 50 mg and 100 mg Application
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 26 Dec 2006
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Dec 2006
Barr Confirms Generic Thalomid(R) Capsule Application
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Nov 2006
Barr's Subsidiary PLIVA Receives Approval for Pravastatin Tablets 10mg, 20mg, and 40mg and Tentative Approval for 80mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Nov 2006
Barr Receives Tentative Approval for a Generic Version of ZYPREXA(R) Zydis(R) Tablets, 5mg, 10mg, 15mg and 20mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 6 Nov 2006
Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2006
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
Biopharmaceuticals Generics Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
PLIVA d.d.
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.